Cann Group Limited (CNGGF) Research

Cann Group Limited specializes in the end-to-end process of bringing medicinal cannabis to market. Its activities span from genetic development and cultivation to product manufacturing, clinical trials, and ultimately, the supply of therapeutic cannabis for both Australian consumption and international export. The company holds specific licenses enabling it to conduct research and grow cannabis for human medicinal and scientific study. Founded in 2014, Cann Group Limited operates out of its base in Port Melbourne, Australia.

Market snapshot

Symbol
CNGGF
Price
$0.00
Day change
0.00%
Market cap
$2.8M
P/E ratio
0.23x
52-week range
0.0015-0.0278
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 months

Peer companies

  • Avant Brands Inc. (AVTBF)
  • Core One Labs Inc. (CLABF)
  • Captiva Verde Wellness Corp. (CPIVF)
  • Canntab Therapeutics Limited (CTABF)
  • LFTD Partners Inc. (LIFD)
  • Rapid Nutrition PLC (RPNRF)
  • Revive Therapeutics Ltd. (RVVTF)
  • StateHouse Holdings Inc. (STHZF)

Open Cann Group Limited (CNGGF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.